当前位置: 100md首页 > 医学版 > 医学资料 > ppt&课件 > 课件14
编号:30010
Surviving Sepsis Campaign:Internaninal guidelines for management of sever sepsis and septic shock:2008.ppt
http://www.100md.com
    参见附件(372KB)。

    清华大学第一附属医院ICU

    Surviving Sepsis Campaign:

    Internaninal guidelines for

    management of sever sepsis

    and septic shock:2008

    Objective

    To provide an update to the original Surviving Sepsis Campaign clinical management guidelines, "Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock," published in 2004.

    Methods:Grading system

    Underlying methodology:

    * A RCT

    * B Downgraded RCT or upgraded observational studies

    * C Well-done observational studies

    * D Case series or expert opinion

    (RCT: randomized controlled trial)

    Methods:Grading system

    Factors that may decrease the strength of evidence:

    * 1. Poor quality of planning and implementation of available RCTs suggesting high likelihood of bias

    * 2. Inconsistency of results (including problems with subgroup analyses)

    * 3. Indirectness of evidence (differing population, intervention, control, outcomes, comparison)

    * 4. Imprecision of results

    * 5. High likelihood of reporting bias

    Methods:Grading system

    Main factors that may increase the strength of evidence:

    * 1. Large magnitude of effect (direct evidence, relative risk (RR) >2 with no plausible confounders)

    * 2. Very large magnitude of effect with RR >5 and no threats to validity (by two levels)

    * 3. Dose response gradient

    Management of Severe Sepsis

    Management of Severe Sepsis

    A.Initial Resuscitation

    The goals during the first 6 hrs:

    * Central venous pressure (CVP): 8-12mm Hg

    * Mean arterial pressure (MAP) ≥ 65mm Hg

    * Urine output ≥ 0.5mL/kg/hr

    * Central venous (superior vena cava) or mixed venous oxygen saturation ≥ 70% or ≥ 65%, respectively(Grade 1C)

    Management of Severe Sepsis

    A.Initial Resuscitation

    Rationale:

    * Early goal therapy improves survival

    * Reduce 28-day mortality rate

    * Although blood lactate concentration may lack precision as a measure of tissue metabolic status,elevated levels in sepsis support aggressive resuscitation.

    Management of Severe Sepsis

    Management of Severe Sepsis

    A.Initial Resuscitation

    * Elevated central venous pressures may also be seen with pre-existing clinically significant pulmonary artery hypertension.

    * Although the cause of tachycardia in septic patients may be multifactorial, a decrease in elevated pulse rate with fluid resuscitation is often a useful marker of improving intravascular filling.

    Management of Severe Sepsis

    A.Initial Resuscitation

    Recently published observational studies

    have demonstrated an association between good

    clinical outcome in septic shock and MAP ≥

    65mm Hg as well as central venous oxygen

    saturation (ScvO2, measured in superior vena

    cava, either intermittently or continuously) of ≥

    70%

    Management of Severe Sepsis

    A.Initial Resuscitation

    We suggest during the first 6 hrs of

    resuscitation of severe sepsis or septic shock, if

    SCVO2 or SvO2 of 70% or 65% respectively is

    not achieved with fluid resuscitation to the CVP

    target, then transfusion of packed red blood cells

    to achieve a hematocrit of ≥ 30% and/or

    administration of a dobutamine infusion (up to a

    maximum of 20ug/kg/min) be utilized to achieve

    this goal (Grade 2C).

    Management of Severe Sepsis

    A.Initial Resuscitation

    Rationale:

    The protocol used in the study cited previously

    targeted an increase in SCVO2 to ≥ 70% . This

    was achieved by sequential institution of initial

    fluid resuscitation, then packed red blood cells,and then dobutamine.This protocol was

    associated with an improvement in survival.

    Management of Severe Sepsis

    B.Diagnosis

    We recommend:

    * Obtaining appropriate cultures before antimicrobial therapy is initiated if such cultures do not cause significant delay in antibiotic administration.

    * At least two blood cultures be obtained prior to

    antibiotics with at least one drawn percutaneously and one drawn through each vascular access device, unless the device was recently (< 48 h) inserted.

    * Cultures of other sites such as urine, cerebrospinal fluid, wounds, respiratory secretions, or other body fluids that may be the source of infection should also be obtained before antibiotic therapy if not associated with significant delay in antibiotic administration(Grade 1C).

    Management of Severe Sepsis

    B.Diagnosis

    Rationale:

    * Samples can be kept in the refrigerator or frozen if processing cannot be performed immediately.

    * Immediate transport to a microbiological lab is necessary.

    * Because rapid sterilization of blood cultures can occur within a few hours after the first antibiotic dose, obtaining those cultures before starting therapy is essential if the causative organism is to be identified.

    Management of Severe Sepsis

    B.Diagnosis

    * Obtaining blood cultures peripherally and through a vascular access device is an importantstrategy.If the same organism is recovered from both cultures, the likelihood that the organism is causing the severe sepsis is enhanced.

    * In addition, if the culture drawn through the vascular access device is positive much earlier than the peripheral blood culture (i. e., > 2 hrs earlier), the data support the concept that the vascular access device is the source of the infection.

    Management of Severe Sepsis

    B.Diagnosis

    * Quantitative cultures of catheter and peripheral blood are also useful for determining whether the catheter is the source of infection. Volume of blood drawn with the culture tube should be at least 10 ml.

    * Quantitative (or semi-quantitative) cultures of respiratory tract secretions are recommended for the diagnosis of ventilator-associated pneumonia.

    * Gram stain can be useful, in particular for respiratory tract specimens,to help decide the micro-organisms to be targeted.......(后略) ......